Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled study of HP-5070 in primary palmar hyperhidrosis
jRCT2031200142Completed
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Primary hyperhidrosis (PH) comparing HP-5070 arm with Placebo arm (2 arms). Primary endpoint: Sweat volume responder rate. Started Oct 2020; status: completed.
02
Drugs
oxybutynin hydrochloride
03
Conditions
Primary hyperhidrosis (PH)
Beyond the preview
Go deeper on jRCT2031200142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200142.